Literature DB >> 3469333

Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.

H Sakahara, K Endo, T Nakashima, M Koizumi, M Kunimatsu, Y Kawamura, H Ohta, T Nakamura, H Tanaka, Y Kotoura.   

Abstract

Monoclonal antibody OST7 reacts specifically with human osteogenic sarcoma. Whole immunoglobulin G (IgG) and the F(ab')2 fragment of OST7 were labeled with radioiodine and indium-111 (111I), and injected into athymic nude mice bearing xenografts of human osteogenic sarcoma (KT005). All radiolabels retained their antigen-binding activities allowing clear visualization of transplanted tumors. Tissue distribution, however, varied. The net tumor concentration of 111In-lableled whole IgG was higher and was retained longer than that of radioiodinated one, but 111In-labeled antibody showed a lower tumor-to-liver and tumor-to-kidney ratio. In radioiodinated OST7, F(ab')2 fragments provided much better images with much higher tumor-to-tissue ratios than whole IgG. Using F(ab')2 fragments as a carrier for 111In, little image improvement was obtained due to the high radioactivity in the liver and kidney. The different distributions among these radiolabels suggest that the choice between intact igG and F(ab')2 fragments and between radioiodine and 111In depends on the intended use.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3469333

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.

Authors:  J Knop; G Delling; U Heise; K Winkler
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

2.  A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.

Authors:  H Kobayashi; H Sakahara; T Saga; M Hosono; M Shirato; H Kanda; K Ishibashi; T Watanabe; K Endo; I Ishiwata
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

3.  Scintigraphic detection of xenografted tumors producing human basic fibroblast growth factor.

Authors:  H Kobayashi; H Sakahara; M Hosono; M Shirato; J Konishi; J A Takahashi; Y Oda; H Kikuchi; K Endo; Y Kozai
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

4.  Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice.

Authors:  N Watanabe; N Oriuchi; S Sugiyama; M Kuroki; Y Matsuoka
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

5.  Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.

Authors:  H Sakahara; H Onodera; M Shirato; Z Yao; G Ohshio; H Kobayashi; M Hosono; S Yano; H Nakada; M Imamura
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

6.  Changes in CA125 release and surface expression caused by drugs in uterine cervix adenocarcinoma cells.

Authors:  T Nakai; H Sakahara; K Endo; M Shirato; H Kobayashi; M Hosono; T Saga; M Sakamoto; J Konishi
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

7.  Reduced bone marrow uptake of indium-111 labelled monoclonal antibody after radiotherapy.

Authors:  H Sakahara; H Onodera; H Kobayashi; Z Yao; I Yamashina; J Konishi
Journal:  Eur J Nucl Med       Date:  1994-11

8.  Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody.

Authors:  H Kobayashi; H Sakahara; M Hosono; M Shirato; S Kondo; S Miyatake; H Kikuchi; Y Namba; K Endo; J Konishi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.

Authors:  Y Nakamoto; H Sakahara; T Saga; N Sato; S Zhao; Y Arano; Y Fujioka; H Saji; J Konishi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma.

Authors:  M Koizumi; K Endo; Y Watanabe; T Saga; H Sakahara; J Konishi; Y Arano; Y Miyachi; M Kashihara-Sawami; S Imamura
Journal:  Jpn J Cancer Res       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.